AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Cohen & Steers, Inc.

$74.95 +$11.38 (+17.90%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$76.66
Day Range
$74.8$78.48
Year Range
$58.39$86.56
Market Cap
3.85B
AVG Volume
273.29K
Trailing/Forward PE
22.92/18.97
PEG ratio
1.72
Dividend Yield
3.51%
Next Earnings Date
2026-10-15
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CNS Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q2599.09M
26 Q1574.61M
25 Q4567.8M
25 Q3568.73M
25 Q2565.63M
25 Q1549.97M
24 Q4536.76M
24 Q3515.43M
24 Q2500.54M
24 Q1497.82M
Net Income (USD) · TTM
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CNS Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2168.3M
26 Q1155.81M
25 Q4153.22M
25 Q3164.16M
25 Q2162.12M
25 Q1157.04M
24 Q4151.26M
24 Q3135.26M
24 Q2127.73M
24 Q1127.74M
Operating Income (USD) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CNS Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2207.31M
26 Q1183.67M
25 Q4177.74M
25 Q3186.76M
25 Q2182.74M
25 Q1177.81M
24 Q4172.88M
24 Q3161.41M
24 Q2157.4M
24 Q1159.84M
EBITDA (USD) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CNS EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2228.97M
26 Q1206.82M
25 Q4200.44M
25 Q3214.75M
25 Q2216.06M
25 Q1209.94M
24 Q4203.39M
24 Q3193.71M
24 Q2186.12M
24 Q1189.11M
Cash Flows (USD) · TTM
-200M-100M0100M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CNS Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2123.32M
26 Q1-12.82M
25 Q4-71.48M
25 Q3-94.05M
25 Q2-122.43M
25 Q1-25.52M
24 Q485.04M
24 Q399.62M
24 Q2124.06M
24 Q1135.06M
EPS (USD) · TTM
0123424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CNS EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q23.26
26 Q13.03
25 Q42.98
25 Q33.19
25 Q23.15
25 Q13.06
24 Q42.97
24 Q32.68
24 Q22.56
24 Q12.57
Expenses (USD) · TTM
050M100M150MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CNS Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q239.78M
26 Q158.97M
25 Q477.21M
25 Q375.18M
25 Q272.2M
25 Q170.91M
24 Q471.79M
24 Q382.48M
24 Q2107.75M
24 Q1121.1M
Shares Outstanding (USD) · TTM
-75M-50M-25M025M50MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CNS Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-49.87M
26 Q1-50.52M
25 Q4-42.04M
25 Q3-18.35M
25 Q2-20.72M
25 Q1-22.96M
24 Q4-31.2M
24 Q3-32.14M
24 Q2-28.57M
24 Q1-26.31M
Dividends (USD)
00.20.40.60.8May 24Aug 24Nov 24Mar 25May 25Aug 25Nov 25Mar 26May 26Aug 26
CNS Dividends (USD) by quarter
PeriodDividends (USD)
Aug 260.67
May 260.67
Mar 260.67
Nov 250.62
Aug 250.62
May 250.62
Mar 250.62
Nov 240.59
Aug 240.59
May 240.59
Employee Count
02004006002016201720182019202020212022202320242025
CNS Employee Count by quarter
PeriodEmployee Count
2025424
2024411
2023405
2022388
2021354
2020347
2019328
2018328
2017303
2016287
PE Ratio
1020304050med 24.54Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CNS PE Ratio by quarter
PeriodPE Ratio
Sep 2622.95
Sep 2624.47
Aug 2625.34
Aug 2624.94
Aug 2625.95
Aug 2625.6
Jul 2625.2
Jul 2626.86
Jul 2627.95
Jul 2625.55
Jul 2625.94
Jun 2625.88
Jun 2624.72
Jun 2625.44
Jun 2624.41
May 2623.05
May 2623.72
May 2623.59
May 2624.02
May 2622.88
Apr 2622.65
Apr 2622.3
Apr 2621.12
Apr 2620.96
Mar 2620.34
Mar 2620.8
Mar 2620.91
Mar 2621.73
Feb 2622.36
Feb 2621.05
Feb 2620.91
Feb 2619.67
Jan 2620.16
Jan 2620.68
Jan 2622.09
Jan 2621.34
Jan 2619.94
Dec 2520.14
Dec 2519.56
Dec 2519.62
Dec 2519.51
Nov 2519.84
Nov 2519.26
Nov 2520.31
Nov 2521.49
Oct 2521.43
Oct 2522.52
Oct 2521.97
Oct 2520.88
Oct 2520.72
Sep 2520.96
Sep 2521.65
Sep 2522.6
Sep 2522.89
Aug 2523.31
Aug 2524.07
Aug 2523.65
Aug 2523.11
Aug 2522.79
Jul 2524.45
Jul 2523.63
Jul 2524.96
Jul 2525.36
Jun 2525.4
Jun 2524.34
Jun 2524.6
Jun 2524.82
May 2524.98
May 2524.63
May 2526.93
May 2526.11
May 2525.51
Apr 2525.62
Apr 2524.97
Apr 2524.74
Apr 2525.47
Mar 2526.41
Mar 2526.54
Mar 2526.13
Mar 2529.39
Feb 2529.39
Feb 2529.03
Feb 2532.01
Feb 2533.41
Jan 2533.27
Jan 2533.34
Jan 2533.12
Jan 2532.2
Jan 2534.76
Dec 2435.04
Dec 2434.72
Dec 2437.18
Dec 2437.77
Nov 2439.29
Nov 2438.82
Nov 2437.72
Nov 2439
Nov 2438.7
Oct 2439.47
Oct 2442.03
Free Cash Flow Yield
-4%-2%0%2%4%med -0.63%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CNS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 263.19%
Sep 262.99%
Aug 262.89%
Aug 262.94%
Aug 262.82%
Aug 262.86%
Jul 262.91%
Jul 26-0.31%
Jul 26-0.29%
Jul 26-0.32%
Jul 26-0.32%
Jun 26-0.32%
Jun 26-0.33%
Jun 26-0.32%
Jun 26-0.34%
May 26-0.36%
May 26-0.35%
May 26-0.35%
May 26-0.34%
May 26-0.36%
Apr 26-2.06%
Apr 26-2.09%
Apr 26-2.21%
Apr 26-2.23%
Mar 26-2.29%
Mar 26-2.24%
Mar 26-2.23%
Mar 26-2.15%
Feb 26-2.09%
Feb 26-2.72%
Feb 26-2.74%
Feb 26-2.91%
Jan 26-2.84%
Jan 26-2.77%
Jan 26-2.59%
Jan 26-2.68%
Jan 26-2.87%
Dec 25-2.84%
Dec 25-2.93%
Dec 25-2.92%
Dec 25-2.94%
Nov 25-2.89%
Nov 25-2.98%
Nov 25-2.82%
Nov 25-2.67%
Oct 25-2.67%
Oct 25-3.35%
Oct 25-3.44%
Oct 25-3.62%
Oct 25-3.65%
Sep 25-3.6%
Sep 25-3.49%
Sep 25-3.34%
Sep 25-3.3%
Aug 25-3.24%
Aug 25-3.14%
Aug 25-3.19%
Aug 25-3.27%
Aug 25-3.31%
Jul 25-0.66%
Jul 25-0.69%
Jul 25-0.65%
Jul 25-0.64%
Jun 25-0.64%
Jun 25-0.67%
Jun 25-0.66%
Jun 25-0.65%
May 25-0.65%
May 25-0.66%
May 25-0.6%
May 25-0.62%
May 25-0.64%
Apr 252.19%
Apr 252.25%
Apr 252.27%
Apr 252.21%
Mar 252.13%
Mar 252.12%
Mar 252.15%
Mar 251.91%
Feb 251.91%
Feb 251.94%
Feb 252.3%
Feb 252.2%
Jan 252.21%
Jan 252.21%
Jan 252.22%
Jan 252.29%
Jan 252.12%
Dec 242.1%
Dec 242.12%
Dec 241.98%
Dec 241.95%
Nov 241.87%
Nov 241.9%
Nov 241.95%
Nov 241.89%
Nov 242.51%
Oct 242.46%
Oct 242.31%
Price to Sales
4681012med 6.91Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CNS Price to Sales by quarter
PeriodPrice to Sales
Sep 266.45
Sep 266.88
Aug 267.12
Aug 267.01
Aug 267.29
Aug 267.19
Jul 267.08
Jul 267.28
Jul 267.58
Jul 266.93
Jul 267.03
Jun 267.02
Jun 266.7
Jun 266.9
Jun 266.62
May 266.25
May 266.43
May 266.4
May 266.51
May 266.2
Apr 266.11
Apr 266.02
Apr 265.7
Apr 265.65
Mar 265.49
Mar 265.61
Mar 265.64
Mar 265.86
Feb 266.03
Feb 266.08
Feb 266.04
Feb 265.68
Jan 265.82
Jan 265.97
Jan 266.38
Jan 266.16
Jan 265.76
Dec 255.81
Dec 255.64
Dec 255.66
Dec 255.63
Nov 255.73
Nov 255.56
Nov 255.86
Nov 256.2
Oct 256.19
Oct 256.45
Oct 256.3
Oct 255.98
Oct 255.94
Sep 256.01
Sep 256.2
Sep 256.48
Sep 256.56
Aug 256.68
Aug 256.9
Aug 256.78
Aug 256.63
Aug 256.53
Jul 256.98
Jul 256.75
Jul 257.13
Jul 257.24
Jun 257.25
Jun 256.95
Jun 257.03
Jun 257.09
May 257.13
May 257.03
May 257.69
May 257.46
May 257.28
Apr 257.22
Apr 257.04
Apr 256.97
Apr 257.18
Mar 257.44
Mar 257.48
Mar 257.36
Mar 258.28
Feb 258.28
Feb 258.18
Feb 258.4
Feb 258.77
Jan 258.73
Jan 258.75
Jan 258.69
Jan 258.45
Jan 259.12
Dec 249.2
Dec 249.11
Dec 249.76
Dec 249.91
Nov 2410.31
Nov 2410.19
Nov 249.9
Nov 2410.23
Nov 249.88
Oct 2410.07
Oct 2410.73
EV/EBITDA
1015202530med 17.75Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CNS EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2614.79
Sep 2615.9
Aug 2616.54
Aug 2616.24
Aug 2616.99
Aug 2616.73
Jul 2616.43
Jul 2620.64
Jul 2621.46
Jul 2619.65
Jul 2619.94
Jun 2619.9
Jun 2619.03
Jun 2619.57
Jun 2618.79
May 2617.76
May 2618.27
May 2618.17
May 2618.5
May 2617.64
Apr 2617.27
Apr 2617.01
Apr 2616.11
Apr 2615.98
Mar 2615.52
Mar 2615.86
Mar 2615.94
Mar 2616.57
Feb 2617.06
Feb 2615.37
Feb 2615.26
Feb 2614.31
Jan 2614.69
Jan 2615.08
Jan 2616.16
Jan 2615.59
Jan 2614.52
Dec 2514.67
Dec 2514.22
Dec 2514.27
Dec 2514.19
Nov 2514.44
Nov 2514
Nov 2514.8
Nov 2515.7
Oct 2515.66
Oct 2516.48
Oct 2516.08
Oct 2515.26
Oct 2515.13
Sep 2515.32
Sep 2515.83
Sep 2516.55
Sep 2516.77
Aug 2517.08
Aug 2517.65
Aug 2517.33
Aug 2516.93
Aug 2516.69
Jul 2517.94
Jul 2517.33
Jul 2518.33
Jul 2518.63
Jun 2518.65
Jun 2517.86
Jun 2518.06
Jun 2518.22
May 2518.34
May 2518.08
May 2519.8
May 2519.19
May 2518.74
Apr 2518.23
Apr 2517.74
Apr 2517.57
Apr 2518.11
Mar 2518.82
Mar 2518.91
Mar 2518.6
Mar 2521.03
Feb 2521.03
Feb 2520.76
Feb 2521.56
Feb 2522.54
Jan 2522.45
Jan 2522.5
Jan 2522.34
Jan 2521.7
Jan 2523.49
Dec 2423.68
Dec 2423.46
Dec 2425.18
Dec 2425.59
Nov 2426.65
Nov 2426.32
Nov 2425.55
Nov 2426.45
Nov 2425.89
Oct 2426.41
Oct 2428.17
Price/Operating Cashflow
1020304050med 21.75Sep 23Jan 24Apr 24Aug 24Nov 24Feb 25Sep 26
CNS Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2630.39
Sep 2632.41
Aug 2633.55
Aug 2633.02
Aug 2634.36
Aug 2633.9
Jul 2633.36
Apr 2540.08
Apr 2539.06
Apr 2538.7
Apr 2539.84
Mar 2541.32
Mar 2541.51
Mar 2540.87
Mar 2545.98
Feb 2545.97
Feb 2545.41
Feb 2535.95
Feb 2537.52
Jan 2537.37
Jan 2537.45
Jan 2537.19
Jan 2536.17
Jan 2539.04
Dec 2439.36
Dec 2438.99
Dec 2441.76
Dec 2442.41
Nov 2444.13
Nov 2443.6
Nov 2442.36
Nov 2443.8
Nov 2429.17
Oct 2429.75
Oct 2431.68
Oct 2427.91
Oct 2428.04
Sep 2428.47
Sep 2428.3
Sep 2427.25
Sep 2426.01
Aug 2426.58
Aug 2426.33
Aug 2425.19
Aug 2424.89
Aug 2424.63
Jul 2422.46
Jul 2421.15
Jul 2419.62
Jul 2418.64
Jun 2418.75
Jun 2418.52
Jun 2418.17
Jun 2417.72
May 2418.17
May 2418.39
May 2418.95
May 2418.28
May 2418.24
Apr 2420.2
Apr 2420.78
Apr 2420.08
Apr 2420.89
Mar 2422.07
Mar 2421.61
Mar 2420.2
Mar 2421.69
Mar 2420.97
Feb 2420.61
Feb 2420.66
Feb 2420.15
Feb 2420.16
Jan 2420.33
Jan 2419.41
Jan 2419.63
Jan 2419.89
Dec 2321.8
Dec 2321.56
Dec 2321.26
Dec 2318.25
Dec 2317.45
Nov 2316.3
Nov 2316.78
Nov 2315.21
Nov 2316.32
Oct 2316.79
Oct 2317.17
Oct 2318.52
Oct 2319.73
Sep 2320.73
Sep 2320.24
Sep 2321.09
Sep 2320.71
Sep 2321.63
Aug 2320.65
Aug 2321.01
Aug 2321.81
Aug 2321.32
Jul 2320.65
Jul 2320.94
Price to Book
4681012med 6.19Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CNS Price to Book by quarter
PeriodPrice to Book
Sep 265.56
Sep 265.92
Aug 266.13
Aug 266.04
Aug 266.28
Aug 266.2
Jul 266.1
Jul 266.27
Jul 266.53
Jul 265.97
Jul 266.06
Jun 266.05
Jun 265.78
Jun 265.94
Jun 265.7
May 265.38
May 265.54
May 265.51
May 265.61
May 265.34
Apr 265.47
Apr 265.39
Apr 265.11
Apr 265.07
Mar 264.92
Mar 265.03
Mar 265.05
Mar 265.25
Feb 265.41
Feb 265.97
Feb 265.93
Feb 265.57
Jan 265.71
Jan 265.86
Jan 266.26
Jan 266.05
Jan 265.65
Dec 255.71
Dec 255.54
Dec 255.56
Dec 255.53
Nov 255.62
Nov 255.46
Nov 255.76
Nov 256.09
Oct 256.07
Oct 256.73
Oct 256.57
Oct 256.24
Oct 256.19
Sep 256.27
Sep 256.47
Sep 256.76
Sep 256.84
Aug 256.97
Aug 257.2
Aug 257.07
Aug 256.91
Aug 256.81
Jul 255.99
Jul 255.79
Jul 256.11
Jul 256.21
Jun 256.22
Jun 255.96
Jun 256.02
Jun 256.08
May 256.12
May 256.03
May 256.59
May 256.39
May 256.25
Apr 256.74
Apr 256.57
Apr 256.51
Apr 256.7
Mar 256.95
Mar 256.98
Mar 256.87
Mar 257.73
Feb 257.73
Feb 257.64
Feb 258.45
Feb 258.82
Jan 258.78
Jan 258.8
Jan 258.74
Jan 258.5
Jan 259.17
Dec 249.25
Dec 249.16
Dec 249.81
Dec 249.97
Nov 2410.37
Nov 2410.25
Nov 249.95
Nov 2410.29
Nov 248.46
Oct 248.63
Oct 249.19
Cohen & Steers, Inc.
CNS
Stockpicker

Video analysis: CNS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CNS

Pasqal and LG CNS partner to power Next-generation AI Data centers with quantum computing

globenewswire.com · 10 Sep 2026

Pasqal and LG CNS partner to power Next-generation AI Data centers with quantum computing

On the sidelines of the France-Korea State Visit, Pasqal strengthens its long-term presence in South Korea by signing a three-year MoU with LG CNS to develop scalable hybrid AI and quantum computing platforms. On the sidelines of the France-Korea State Visit, Pasqal strengthens its long-term presence in South Korea by signing a three-year MoU with LG CNS to develop scalable hybrid AI and quantum computing platforms.

Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for August 2026

prnewswire.com · 9 Sep 2026

Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for August 2026

NEW YORK, Sept. 9, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $101.0 billion at August 31, 2026, a decrease of $1.5 billion from assets under management of $102.5 billion at July 31, 2026.

FHI vs. CNS: Which Stock Is the Better Value Option?

zacks.com · 9 Sep 2026

FHI vs. CNS: Which Stock Is the Better Value Option?

Investors with an interest in Financial - Investment Management stocks have likely encountered both Federated Hermes (FHI) and Cohen & Steers Inc (CNS). But which of these two companies is the best option for those looking for undervalued stocks?

Corero spikes 10% on $3.9 million UK telecom and NeoCloud deals

proactiveinvestors.co.uk · 2 Sep 2026

Corero spikes 10% on $3.9 million UK telecom and NeoCloud deals

Shares in Corero Network Security PLC (AIM:CNS, OTCQB:DDOSF) rose 10% to 8p after itech vendor secured a combined $3.9 million in new agreements to deploy its sovereign cybersecurity defences across the UK telecommunications sector and the global NeoCloud sector. At the heart of the operational update is a pivotal five-year contract worth $3.4 million with a leading UK-based tier 1 fixed and mobile telecommunications provider.

CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth

accessnewswire.com · 1 Sep 2026

CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth

Chief Business Officer, Dylan Wenke, Participates in Virtual Investor "What This Means" Segment Access the segment here HOUSTON, TX / ACCESS Newswire / September 1, 2026 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today announced that it participated in a Virtual Investor "What This Means" Segment. Dylan Wenke, Chief Business Officer of CNS Pharmaceuticals, provided an update on its business development strategy as part of its broader transformation as the Company works to establish a pipeline focused on oncology or neurology with best in class potential.

Cohen & Steers and Trademark Acquire Oak Hill Plaza Shopping Center in Austin, Texas

prnewswire.com · 31 Aug 2026

Cohen & Steers and Trademark Acquire Oak Hill Plaza Shopping Center in Austin, Texas

NEW YORK, Aug. 31, 2026 /PRNewswire/ -- Cohen & Steers (NYSE: CNS) announced today that the Cohen & Steers Real Estate Opportunities Fund (REOF) has acquired Oak Hill Plaza, a shopping center in Austin, Texas. The acquisition was made through a joint venture with Trademark Property Company, a real estate investor, developer, and operator with expertise in retail assets in Texas.

Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)

prnewswire.com · 28 Aug 2026

Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, Aug. 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the distribution to be paid on August 31, 2026 and cumulative distributions paid fiscal year-to-date. In March 2015, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)

prnewswire.com · 28 Aug 2026

Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)

NEW YORK, Aug. 28, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of the distribution to be paid on August 31, 2026 and cumulative distributions paid fiscal year-to-date. In December 2021, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by the Securities and Exchange Commission.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.